Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter aβ or tau pathology

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Castello, Nicholas A ^a,b   Green, Kim N ^a,b   LaFerla, Frank M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; TAU PROTEIN;

3XTG AD MOUSE; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE EXACERBATION; EXPERIMENTAL MOUSE; GENE SILENCING; MOUSE; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PREMATURE MORTALITY; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; NEURONS; TAU PROTEINS;

MUS;

EID: 84864533900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039566     Document Type: Article

References (38)

1. Querfurth HW, LaFerla FM, ((2010)) Alzheimer's disease. N Engl J Med 362:: 329-344.
2. McAllister AK, Katz LC, Lo DC, ((1999)) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:: 295-318.
3. Bartoletti A, Cancedda L, Reid SW, Tessarollo L, Porciatti V, et al. ((2002)) Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation. J Neurosci 22:: 10072-10077.
4. JA ZeilerSR, Tamowski S, Jones KR, ((2003)) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23:: 6856-6865.
5. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ, ((2007)) Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 12:: 656-670.
6. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, et al. ((2004)) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 101:: 10827-10832.
7. Peng S, Wuu J, Mufson EJ, Fahnestock M, ((2005)) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93:: 1412-1421.
8. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M, ((2000)) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 76:: 347-354.
9. Connor B, Young D, Yan Q, Faull RL, Synek B, et al. ((1997)) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49:: 71-81.
10. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S, ((2008)) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59:: 201-220.
11. Aliaga E, Silhol M, Bonneau N, Maurice T, Arancibia S, et al. ((2010)) Dual response of BDNF to sublethal concentrations of β-amyloid peptides in cultured cortical neurons. Neurobiol Dis 37:: 208-217.
12. Tong L, Balazs R, Thornton PL, Cotman CW, ((2004)) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 24:: 6799-6809.
13. Garzon DJ, Fahnestock M, ((2007)) Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27:: 2628-2635.
14. Zheng Z, Sabirzhanov B, Keifer J, ((2010)) Oligomeric amyloid-{beta} inhibits the proteolytic conversion of brain-derived neurotrophic factor (BDNF), AMPA receptor trafficking, and classical conditioning. J Biol Chem 285:: 34708-34717.
15. Akatsu H, Yamagata HD, Kawamata J, Kamino K, Takeda M, et al. ((2006)) Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn Disord 22:: 216-222.
16. Huang R, Huang J, Cathcart H, Smith S, Poduslo SE, ((2007)) Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet 44:: e66.
17. Bodner SM, Berrettini W, van Deerlin V, Bennett DA, Wilson RS, et al. ((2005)) Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 134B:: 1-5.
18. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, et al. ((2001)) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6:: 83-86.
19. Fukumoto N, Fujii T, Combarros O, Kamboh MI, Tsai S-J, et al. ((2010)) Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 153B:: 235-242.
20. Olin D, MacMurray J, Comings DE, ((2005)) Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett 381: 275-278.
21. Arancibia S, Silhol M, Moulière F, Meffre J, (null), et al ((2008)) Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 31:: 316-326.
22. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P, ((2008)) NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proc Natl Acad Sci USA 105:: 13139-13144.
23. Elliott E, Atlas R, Lange A, Ginzburg I, ((2005)) Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur J Neurosci 22:: 1081-1089.
24. Ernfors P, Lee KF, Jaenisch R, ((1994)) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:: 147-150.
25. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. ((2003)) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:: 409-421.
26. Oddo S, Caccamo A, Green KN, Liang K, Tran L, et al. ((2005)) Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci USA 102:: 3046-3051.
27. Reichardt LF, ((2006)) Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society B: Biological Sciences 361:: 1545-1564.
28. Pitts AF, Miller MW, ((2000)) Expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 in the somatosensory cortex of the mature rat: coexpression with high-affinity neurotrophin receptors. J Comp Neurol 418:: 241-254.
29. Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, et al. ((2008)) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28:: 11500-11510.
30. Green KN, Khashwji H, Estrada T, LaFerla FM, ((2011)) ST101 induces a novel 17 kDa APP cleavage that precludes Aβ generation in vivo. Ann Neurol 69:: 831-844.
31. Rohe M, Synowitz M, Glass R, Paul SM, Nykjaer A, et al. ((2009)) brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression. J Neurosci 29:: 15472-15478.
32. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, et al. ((2000)) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:: 771-782.
33. Ge Y-W, Lahiri DK, ((2002)) Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann N Y Acad Sci 973:: 463-467.
34. Ruiz-León Y, Pascual A, ((2001)) Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1-independent mechanism in SH-SY5Y neuroblastoma cells. J Neurochem 79:: 278-285.
35. Schmidt V, Sporbert A, Rohe M, Reimer T, Rehm A, et al. ((2007)) SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1. J Biol Chem 282:: 32956-32964.
36. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller F-J, et al. ((2009)) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 106:: 13594-13599.
37. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, et al. ((2009)) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15:: 331-337.
38. Green K, Steffan J, Martinez-Coria H, ((2008)) Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci.